PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+0.37%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.56B
AUM Growth
-$92.1M
(-5.6%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
77.78%
Holding
44
New
2
Increased
8
Reduced
7
Closed
7
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$19.1M |
| 2 |
eHealth
EHTH
|
+$12M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
+$6.97M |
| 4 |
Biogen
BIIB
|
+$5.61M |
| 5 |
Alkermes
ALKS
|
+$3.82M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$17.3M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
+$15M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$11.1M |
| 4 |
AstraZeneca
AZN
|
+$10M |
| 5 |
Puma Biotechnology
PBYI
|
+$9.77M |
Sector Composition
| 1 | Healthcare | 97.34% |
| 2 | Financials | 2.63% |
